• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    3/22/24 2:39:16 PM ET
    $ABTS
    $AIR
    $AMTX
    $ANNX
    Computer Software: Programming Data Processing
    Technology
    Aerospace
    Industrials
    Get the next $ABTS alert in real time by email

    Shares of Cutera, Inc. (NASDAQ:CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.

    Cutera posted adjusted loss of $1.36 per share, compared to market estimates for a loss of 94 cents per share. The company’s quarterly sales came in at $49.540 million, versus expectations of $47.500 million, according to data from Benzinga Pro.

    Cutera shares dipped 26.5% to $1.6899 on Friday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Murano Global Investments PLC (NASDAQ:MRNO) shares jumped 147.5% to $23.94 after falling 46% on Thursday.
    • Nova LifeStyle, Inc. (NASDAQ:NVFY) surged 120% to $4.0301 after gaining around 22% on Thursday.
    • BIOLASE, Inc. (NASDAQ:BIOL) shares climbed 50.4% to $0.2256 after the company reported better-than-expected fourth-quarter earnings results.
    • IMAC Holdings, Inc. (NASDAQ:BACK) gained 41.1% to $1.8204.
    • Summit Midstream Partners, LP (NYSE:SMLP) surged 36.1% to $26.45 after the company announced the sale of its Utica position for $625 million.
    • Outlook Therapeutics, Inc. (NASDAQ:OTLK) gained 32.1% to $9.30 after the company announced it received a positive European Union CHMP opinion for ONS-5010 as a treatment for Wet AMD.
    • GT Biopharma, Inc. (NASDAQ:GTBP) gained 27.6% to $4.86.
    • Aemetis, Inc. (NASDAQ:AMTX) rose 21% to $6.21. Aemetis recently announced approval by the U.S. Citizenship and Immigration Services for a $200 million of EB-5 program investment for the Riverbank sustainable aviation fuel, production plant, the dairy renewable natural gas project, the carbon sequestration project and energy efficiency upgrades to the Keyes ethanol plant.
    • Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) gained 20.4% to $1.1796. Foresight Autonomous said Eye-Net and Softbank completed technology validation phase for connected mobility applications in Japan.
    • Intellicheck, Inc. (NASDAQ:IDN) gained 19.4% to $2.09 after the company reported a year-over-year increase in fourth-quarter EPS results.
    • Worthington Steel, Inc. (NYSE:WS) climbed 18.8% to $37.92 as the company posted stronger-than-expected results for its third quarter on Thursday.
    • Canopy Growth Corporation (NASDAQ:CGC) rose 18.6% to $5.41.
    • Annexon, Inc. (NASDAQ:ANNX) climbed 17.3% to $7.14.
    • Ocugen, Inc. (NASDAQ:OCGN) gained 12.5% to $1.5090 after gaining 8% on Thursday. Ocugen recently appointed Huma Qamar, MD, MPH as Chief Medical Officer.
    • Lithium Americas (Argentina) Corp. (NYSE:LAAC) rose 12.2% to $5.77.
    • Dianthus Therapeutics, Inc. (NASDAQ:DNTH) surged 11% to $30.84 following upbeat results.
    • Griid Infrastructure Inc. (NASDAQ:GRDI) gained 10.9% to $1.22.
    • Astera Labs, Inc. (NASDAQ:ALAB) rose 9.6% to $70.30.
    • FedEx Corporation (NYSE:FDX) rose gained 7.9% to $285.78 after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion share repurchase program.
    • Foot Locker, Inc. (NYSE:FL) rose 5% to $24.85. Citigroup analyst Paul Lejuez upgraded Foot Locker from Sell to Neutral and announced a $24 price target.

    Losers

    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) shares fell 36.4% to $2.32. BYND Cannasoft said that the previously announced 1-for-190 reverse stock split of its outstanding shares of common stock has been made effective today, March 22, 2024.
    • Sintx Technologies, Inc. (NASDAQ:SINT) fell 30.4% to $0.0946 after the company announced a proposed public offering of common stock.
    • Ispire Technology Inc. (NASDAQ:ISPR) fell 28% to $5.84 after the company announced the pricing of its public offering of 2.05 million shares of common stock at $6.00 per share.
    • Brand Engagement Network, Inc. (NASDAQ:BNAI) declined 27.2% to $8.00.
    • Nkarta, Inc. (NASDAQ:NKTX) fell 22.2% to $10.10 after the company reported fourth-quarter financial results. Following earnings, Raymond James downgraded the stock from Strong Buy to Outperform.
    • Yield10 Bioscience, Inc. (NASDAQ:YTEN) fell 22.7% to $0.3358. Yield10 Bioscience recently announced that the USDA-APHIS Biotechnology Regulatory Services determined that the Camelina sativa varieties may be planted and bred in the United States.
    • ReTo Eco-Solutions, Inc. (NASDAQ:RETO) declined 20% to $1.50.
    • Aterian, Inc. (NASDAQ:ATER) fell 18.3% to $2.66.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) dipped 18% to $0.6026.
    • Lululemon Athletica Inc. (NASDAQ:LULU) tumbled 16.6% to $399.36. Lululemon posted better-than-expected results for its fourth quarter, but issued a weak forecast for the first quarter.
    • TROOPS, Inc. (NASDAQ:TROO) declined 16.3% to $1.3798.
    • Li-Cycle Holdings Corp. (NYSE:LICY) dipped 14% to $1.1096.
    • Cazoo Group Ltd (NYSE:CZOO) fell 13.8% to $4.0480.
    • Selina Hospitality PLC (NASDAQ:SLNA) fell 12.9% to $0.2439 after jumping around 30% on Thursday.
    • Grifols, S.A. (NASDAQ:GRFS) fell 11.3% to $6.01.
    • Abits Group Inc. (NASDAQ:ABTS) dipped 9.9% to $0.6991 after declining over 6% on Thursday.
    • Bitdeer Technologies Group (NASDAQ:BTDR) fell 9.8% to $7.17.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) fell 9.2% to $3.2950.
    • Next.e.GO N.V. (NASDAQ:EGOX) shares fell 9% to $0.0458 after dipping 16% on Thursday.
    • NIKE, Inc. (NYSE:NKE) shares tumbled 8.1% to $92.63. Nike reported upbeat earnings and sales results for its third quarter on Thursday.
    • JOANN Inc. (NASDAQ:JOAN) shares fell 7.8% to $0.1420 after surging 14% on Thursday.
    • AAR Corp. (NYSE:AIR) fell 5.9% to $60.14 following downbeat sales.

     

    Now Read This: Bitcoin Falls Below $65,000; Ondo, Solana Among Top Losers

    Get the next $ABTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABTS
    $AIR
    $AMTX
    $ANNX

    CompanyDatePrice TargetRatingAnalyst
    lululemon athletica inc.
    $LULU
    3/12/2026$303.00 → $250.00Buy
    BTIG Research
    Ocugen Inc.
    $OCGN
    3/11/2026$10.00Outperform
    Oppenheimer
    Nike Inc.
    $NKE
    3/11/2026$73.00Equal Weight → Overweight
    Barclays
    Dianthus Therapeutics Inc.
    $DNTH
    3/10/2026$123.00Outperform → Strong Buy
    Raymond James
    FedEx Corporation
    $FDX
    2/25/2026$335.00Hold → Reduce
    HSBC Securities
    FedEx Corporation
    $FDX
    2/13/2026$313.00 → $383.00Buy
    TD Cowen
    Kingsoft Cloud Holdings Limited
    $KC
    2/11/2026$15.60Neutral → Buy
    Goldman
    FedEx Corporation
    $FDX
    2/3/2026$380.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $ABTS
    $AIR
    $AMTX
    $ANNX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research reiterated coverage on lululemon athletica with a new price target

    BTIG Research reiterated coverage of lululemon athletica with a rating of Buy and set a new price target of $250.00 from $303.00 previously

    3/12/26 8:14:44 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    Oppenheimer initiated coverage on Ocugen with a new price target

    Oppenheimer initiated coverage of Ocugen with a rating of Outperform and set a new price target of $10.00

    3/11/26 8:39:19 AM ET
    $OCGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    NIKE upgraded by Barclays with a new price target

    Barclays upgraded NIKE from Equal Weight to Overweight and set a new price target of $73.00

    3/11/26 8:29:15 AM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    $ABTS
    $AIR
    $AMTX
    $ANNX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF ACCOUNTING OFFICER Carr Edward exercised 43,682 shares at a strike of $20.45 and sold $3,559,495 worth of shares (43,682 units at $81.49) (SEC Form 4)

    4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)

    3/13/26 8:30:05 PM ET
    $DNTH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, Head of R&D Randhawa Simrat exercised 33,830 shares at a strike of $18.15 and sold $2,756,468 worth of shares (33,830 units at $81.48) (SEC Form 4)

    4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)

    3/13/26 8:30:03 PM ET
    $DNTH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO AND PRESIDENT Garcia Marino exercised 122,918 shares at a strike of $6.70 and sold $10,016,381 worth of shares (122,918 units at $81.49) (SEC Form 4)

    4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)

    3/13/26 8:30:07 PM ET
    $DNTH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABTS
    $AIR
    $AMTX
    $ANNX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Foresight's Eye-Net Achieves Positive Results in Large-Scale Public Transit Project with Renault and Orange in France

    Following a very successful collaboration, the parties are in active commercial discussions to pursue joint commercialization of the solution Ness Ziona, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) ("Foresight" or the "Company"), an innovator in 3D perception systems, announced that its majority-owned subsidiary, Eye-Net Mobile Ltd. ("Eye-Net"), together with Renault Group, Orange S.A. ("Orange") and other participants, recently announced the successful completion of a large-scale live trial of the SafeCycloMove "Collision Prevention" project in the city of Bordeaux, France. The initiative is a part of Eye-Net's ongoing collaborati

    3/13/26 7:37:00 AM ET
    $FRSX
    Computer Software: Prepackaged Software
    Technology

    Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

    NEW YORK and WALTHAM, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (NASDAQ:DNTH) ("Dianthus" or the "Company"), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced that it closed its previously announced underwritten public offering of 8,470,989 shares of its common stock, including the full exercise by the underwriters of their option to purchase an additional 1,157,407 shares, at a public offering price of $81.00 per share, and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 402,468 shares of its common stock at a pub

    3/12/26 4:01:00 PM ET
    $DNTH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chip Wilson to lululemon CEO Candidates: Beware a Board Unfit to Support Visionary Leadership

    New Open Letter Announces Wilson's Message on the Value of Board Refreshment Ahead of CEO SelectionVANCOUVER, B.C., March 12, 2026 /CNW/ -- Chip Wilson, Founder of lululemon athletica inc. (NASDAQ: LULU) ("lululemon" or the "Company") and one of lululemon's largest shareholders, today issued a letter to leaders in the retail and apparel space who may consider becoming lululemon's next Chief Executive Officer. To Leaders of Technical Apparel Interested in Becoming the Next CEO of lululemon:There are few people who are stronger advocates for technical apparel than I am. To this day, I have an unending passion for every aspect of this space, from leading product reviews to discovering new, inno

    3/12/26 8:00:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    $ABTS
    $AIR
    $AMTX
    $ANNX
    SEC Filings

    View All

    SEC Form 8-K filed by FedEx Corporation

    8-K - FEDEX CORP (0001048911) (Filer)

    3/12/26 5:12:23 PM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form 144 filed by Dianthus Therapeutics Inc.

    144 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Subject)

    3/12/26 4:59:09 PM ET
    $DNTH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Dianthus Therapeutics Inc.

    144 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Subject)

    3/12/26 4:23:46 PM ET
    $DNTH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABTS
    $AIR
    $AMTX
    $ANNX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Carson William H. bought $45,360 worth of shares (8,000 units at $5.67), increasing direct ownership by 15% to 62,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    3/12/26 4:31:34 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Lyons Christopher Michael bought $24,092 worth of shares (8,292 units at $2.91) (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    3/10/26 9:00:18 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Co-Chief Executive Officer Wang Michael Xue bought $11,959 worth of shares (5,000 units at $2.39), increasing direct ownership by 1% to 466,882 units (SEC Form 4)

    4 - Ispire Technology Inc. (0001948455) (Issuer)

    3/2/26 4:58:37 PM ET
    $ISPR
    Medicinal Chemicals and Botanical Products
    Health Care

    $ABTS
    $AIR
    $AMTX
    $ANNX
    Leadership Updates

    Live Leadership Updates

    View All

    Chip Wilson to lululemon CEO Candidates: Beware a Board Unfit to Support Visionary Leadership

    New Open Letter Announces Wilson's Message on the Value of Board Refreshment Ahead of CEO SelectionVANCOUVER, B.C., March 12, 2026 /CNW/ -- Chip Wilson, Founder of lululemon athletica inc. (NASDAQ: LULU) ("lululemon" or the "Company") and one of lululemon's largest shareholders, today issued a letter to leaders in the retail and apparel space who may consider becoming lululemon's next Chief Executive Officer. To Leaders of Technical Apparel Interested in Becoming the Next CEO of lululemon:There are few people who are stronger advocates for technical apparel than I am. To this day, I have an unending passion for every aspect of this space, from leading product reviews to discovering new, inno

    3/12/26 8:00:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    Chip Wilson Provides Update to lululemon Shareholders

    VANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Chip Wilson, Founder of lululemon athletica inc. (NASDAQ:LULU) ("lululemon" or the "Company") and one of lululemon's largest shareholders, today released the following letter to lululemon shareholders: Shareholders of lululemon:In support of all shareholders, I am pursuing a campaign to catalyze a quantum of change that is sorely needed at lululemon. To effect that change, I have pursued private, constructive dialogues with the lululemon Board of Directors (the "Board") for the past few months. My attempts toward a sensible solution have not been reciprocated.The heart of the issue is a disconnect between the Company's creative engine and the Board's str

    2/27/26 8:00:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

    Appointment supports acceleration of revenue opportunities from SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies SALT LAKE CITY, Utah, Feb. 18, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company focused on silicon nitride (SiN) solutions for medical and other high-value applications, today announced the appointment of Ryan Elmore as President of SINTX Technologies, Inc., effective March 16, 2026. Mr. Elmore most recently served as Core Business Director at Invibio, a division of Victrex plc. With more than 15 years of experience in advanced biomaterials and medical dev

    2/18/26 8:30:00 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $ABTS
    $AIR
    $AMTX
    $ANNX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Li-Cycle Holdings Corp.

    SC 13D/A - Li-Cycle Holdings Corp. (0001828811) (Subject)

    12/9/24 6:03:27 PM ET
    $LICY
    Environmental Services
    Industrials

    Amendment: SEC Form SC 13D/A filed by Dianthus Therapeutics Inc.

    SC 13D/A - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Subject)

    12/3/24 9:19:18 PM ET
    $DNTH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABTS
    $AIR
    $AMTX
    $ANNX
    Financials

    Live finance-specific insights

    View All

    Aemetis Reports Fourth Quarter and Full Year 2025 Results as Dairy RNG Platform Scales

    Dairy RNG production increased 61% year over year in Q4 2025; ethanol plant efficiency upgrade expected to increase plant cash flow from operations by approximately $32 million annually Aemetis Biogas segment net income increased to $12.2 million in Q4 2025Aemetis Biogas segment increased annual revenues and production tax credits by 53%Dairy RNG production increased 61% year over year in Q4 2025Aemetis Biogas achieved annual segment net income of $6.9 millionCapital investments increased 28% over the prior year to $26.0 million, supporting dairy RNG expansion and ethanol plant energy efficiency upgradesDairy digester projects generated cash proceeds of $18 million during 2025 from the sale

    3/12/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Intellicheck to Announce Fourth Quarter and Full Year 2025 Financial Results

    Financial Results Conference Call March 19 at 4:30 p.m. ET/1:30 p.m. PT Intellicheck, Inc. (NASDAQ:IDN), an industry-leading identity company delivering proprietary on-demand digital and physical identity validation solutions, will report its financial results on March 19, 2026 for the fourth quarter and full year ended December 31, 2025. The Company will hold an earnings conference call on March 19 at 4:30 p.m. ET/1:30 p.m. PT to discuss its operating results. To listen to the earnings conference call, please dial 877-407-8037. For callers outside the U.S., please dial 201-689-8037. A replay of the conference call will be available approximately two hours after completion of the live

    3/11/26 8:05:00 AM ET
    $IDN
    Computer Software: Prepackaged Software
    Technology

    AAR to announce third quarter fiscal year 2026 results on March 24, 2026

    WOOD DALE, Ill., March 10, 2026 /PRNewswire/ -- AAR CORP. (NYSE:AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, today announced that it will release financial results for its third quarter of fiscal year 2026, ended February 28, 2026, after the close of the New York Stock Exchange trading session on Tuesday, March 24, 2026. On Tuesday, March 24, 2026, at 4 p.m. Central time, AAR will hold a conference call to discuss the results. A listen-only webcast and slides can be accessed at https://edge.media-server.com/mmc/p/8n3xaah2.

    3/10/26 4:05:00 PM ET
    $AIR
    Aerospace
    Industrials